Duzenli O, Aslanidi G
Biomedicines. 2025; 13(2).
PMID: 40002774
PMC: 11852678.
DOI: 10.3390/biomedicines13020361.
Gan C, Leng M, Liu Y, Zheng Z, He S, Qiao W
Mol Ther Methods Clin Dev. 2025; 33(1):101399.
PMID: 39897641
PMC: 11787516.
DOI: 10.1016/j.omtm.2024.101399.
Holtkamp S, Lagoda F, Lister A, Harish P, Kleymann U, Pesch T
Front Immunol. 2024; 15:1450524.
PMID: 39654900
PMC: 11625739.
DOI: 10.3389/fimmu.2024.1450524.
Mnyandu N, Jacobs R, Arbuthnot P, Maepa M
Pharmaceutics. 2024; 16(11).
PMID: 39598484
PMC: 11597783.
DOI: 10.3390/pharmaceutics16111360.
Chen K, Ernst P, Sarkar A, Kim S, Si Y, Varadkar T
Cancer Res. 2024; 84(23):4049-4065.
PMID: 39288077
PMC: 11609628.
DOI: 10.1158/0008-5472.CAN-24-0984.
Sensing of Liver-Derived Nicotinamide by Intestinal Group 2 Innate Lymphoid Cells Links Liver Cirrhosis and Ulcerative Colitis Susceptibility.
Shen J, Li Z, Liu X, Zheng M, Zhang P, Chen Y
Adv Sci (Weinh). 2024; 11(38):e2404274.
PMID: 39119946
PMC: 11481183.
DOI: 10.1002/advs.202404274.
A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo.
Li Y, Chien S, Huang R, Herrmann A, Zhao Q, Li P
Mol Ther. 2024; 32(10):3629-3649.
PMID: 39091030
PMC: 11489542.
DOI: 10.1016/j.ymthe.2024.07.025.
Evaluation of anti-vector immune responses to adenovirus-mediated lung gene therapy and modulation by αCD20.
Clark R, Rabito F, Munyonho F, Remcho T, Kolls J
Mol Ther Methods Clin Dev. 2024; 32(3):101286.
PMID: 39070292
PMC: 11283059.
DOI: 10.1016/j.omtm.2024.101286.
Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies.
Chhabra A, Bashirians G, Petropoulos C, Wrin T, Paliwal Y, Henstock P
Mol Ther Methods Clin Dev. 2024; 32(3):101273.
PMID: 39022744
PMC: 11253686.
DOI: 10.1016/j.omtm.2024.101273.
The Interactions between Cells and Viruses.
Fujimuro M
Int J Mol Sci. 2024; 25(13).
PMID: 38999995
PMC: 11241451.
DOI: 10.3390/ijms25136886.
Roctavian gene therapy for hemophilia A.
Samelson-Jones B, Small J, George L
Blood Adv. 2024; 8(19):5179-5189.
PMID: 38991118
PMC: 11530397.
DOI: 10.1182/bloodadvances.2023011847.
Gene Therapies in Clinical Development to Treat Retinal Disorders.
McClements M, Abdalla Elsayed M, Major L, de la Camara C, MacLaren R
Mol Diagn Ther. 2024; 28(5):575-591.
PMID: 38955952
PMC: 11349810.
DOI: 10.1007/s40291-024-00722-0.
AAV vectors for long-term gene therapy of hemophilia B: Are we there yet?.
Srivastava A
Mol Ther. 2024; 32(7):2042-2044.
PMID: 38906152
PMC: 11286803.
DOI: 10.1016/j.ymthe.2024.06.009.
Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseases.
Esposito F, DellAquila F, Rhiel M, Auricchio S, Chmielewski K, Andrieux G
Cell Rep Med. 2024; 5(7):101619.
PMID: 38897206
PMC: 11293346.
DOI: 10.1016/j.xcrm.2024.101619.
Optimizing liver health before and after gene therapy for hemophilia A.
Ragni M, Mead H, de Jong Y, Kaczmarek R, Leavitt A, Long B
Blood Adv. 2024; 8(19):5203-5212.
PMID: 38843379
PMC: 11530393.
DOI: 10.1182/bloodadvances.2024013059.
Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A.
Long B, Robinson T, Day J, Yu H, Lau K, Imtiaz U
Mol Ther. 2024; 32(7):2052-2063.
PMID: 38796703
PMC: 11286804.
DOI: 10.1016/j.ymthe.2024.05.033.
Miniaturization of hiPSC-derived 3D neural cultures in stirred-tank bioreactors for parallelized preclinical assessment of rAAV.
Gomes C, Sebastiao M, Silva G, Moura F, Simao D, Gomes-Alves P
Front Bioeng Biotechnol. 2024; 12:1379597.
PMID: 38737536
PMC: 11082387.
DOI: 10.3389/fbioe.2024.1379597.
Correlation of antigen expression with epigenetic modifications after rAAV delivery of a human factor IX variant in mice and rhesus macaques.
Pekrun K, Stephens C, Gonzalez-Sandoval A, Goswami A, Zhang F, Tarantal A
Mol Ther. 2024; 32(7):2064-2079.
PMID: 38715361
PMC: 11286812.
DOI: 10.1016/j.ymthe.2024.05.005.
Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance.
Ellakwa D, Mushtaq N, Khan S, Jabbar A, Abdelmalek M, Wadan A
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(8):5617-5630.
PMID: 38619588
DOI: 10.1007/s00210-024-03076-w.
An Innovative Mitochondrial-targeted Gene Therapy for Cancer Treatment.
Chen K, Ernst P, Kim S, Si Y, Varadkar T, Ringel M
bioRxiv. 2024; .
PMID: 38585739
PMC: 10996521.
DOI: 10.1101/2024.03.24.584499.